Peripheral Neuropathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged between 18 and 80 years old
- People who have freely agreed to take part in the study
- People who have been diagnosed with hereditary CMT neuropathy (a nerve condition confirmed through genetic testing)
- People who have been diagnosed with an acquired demyelinating neuropathy, such as typical CIDP or anti-MAG neuropathy in its typical form (nerve conditions where the protective covering of nerves is damaged)
- People who have a confirmed genetic mutation in the transthyretin (TTR) gene, which is linked to a hereditary nerve condition
- People who are enrolled in or entitled to benefits under a French social security scheme
Who may not be able to join:
- People who have another peripheral nerve condition, either currently or in their medical history
- People with a history of alcohol or psychoactive substance misuse
- People who cannot have an MRI scan for any of the following reasons: claustrophobia (fear of enclosed spaces), having a pacemaker, a Holter monitoring device, an IUD (contraceptive coil), metal surgical clips, metal prostheses or implants, or any other metal objects in the body
- People whose disability is too severe to allow them to undergo an MRI scan
- People who are currently participating in another research study that restricts them from joining additional trials
- People in certain protected groups under French law, including minors, adults under legal guardianship, people who are detained, and women who are pregnant or breastfeeding
- People who are not able to read and understand French well enough to provide informed consent to participate
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: François CREMIEUX, Assistance Publique - Hôpitaux de Marseille
Phone: 04 91 38 65 79
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Annual intramuscular fat fraction progression
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.